A group of banks has slashed the pricing on $8.5 billion of leveraged loans to help fund the buyout of medical-device maker Hologic Inc., underscoring strong investor appetite for risk.
Sign in to read the full article.
Sign in with Google
A group of banks has slashed the pricing on $8.5 billion of leveraged loans to help fund the buyout of medical-device maker Hologic Inc., underscoring strong investor appetite for risk.
Sign in to read the full article.
Sign in with Google